Exchange Traded Concepts LLC Decreases Stock Position in Tempus AI, Inc. $TEM

Key Points

• Exchange Traded Concepts LLC sold 6,359 shares of Tempus AI, reducing its holdings by 7.1% in the second quarter, now owning a total of 82,670 shares valued at approximately $5.25 million.
• Significant growth in institutional holdings was seen, with Vanguard Group increasing its stake by over 6,247% in Q1, owning nearly 6 million shares valued at about $289 million.
• Wall Street analysts have expressed optimism for Tempus AI, with price targets being raised by several firms; the stock currently has a consensus rating of "Moderate Buy" and an average price target of $70.17.

Exchange Traded Concepts LLC lowered its holdings in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) by 7.1% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 82,670 shares of the company's stock after selling 6,359 shares during the quarter. Exchange Traded Concepts LLC's holdings in Tempus AI were worth $5,253,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the business. BNP Paribas Financial Markets purchased a new position in shares of Tempus AI in the fourth quarter valued at approximately $78,000. ProShare Advisors LLC purchased a new position in shares of Tempus AI in the fourth quarter valued at approximately $244,000. Two Sigma Advisers LP purchased a new position in shares of Tempus AI in the fourth quarter valued at approximately $625,000. Voloridge Investment Management LLC purchased a new position in shares of Tempus AI in the fourth quarter valued at approximately $11,826,000. Finally, GF Fund Management CO. LTD. purchased a new position in shares of Tempus AI in the fourth quarter valued at approximately $108,000. Hedge funds and other institutional investors own 24.22% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on TEM. BTIG Research raised their target price on Tempus AI from $75.00 to $85.00 and gave the company a "buy" rating in a research report on Wednesday, August 20th. Morgan Stanley raised their target price on Tempus AI from $65.00 to $68.00 and gave the company an "overweight" rating in a research report on Tuesday, August 12th. HC Wainwright increased their price target on Tempus AI from $90.00 to $98.00 and gave the company a "buy" rating in a report on Friday, September 12th. Needham & Company LLC reaffirmed a "buy" rating and issued a $70.00 price target on shares of Tempus AI in a report on Friday, August 8th. Finally, Piper Sandler reaffirmed a "neutral" rating on shares of Tempus AI in a report on Friday, August 8th. Seven research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $70.17.

Insider Buying and Selling at Tempus AI

In related news, CEO Eric P. Lefkofsky sold 332,500 shares of Tempus AI stock in a transaction on Wednesday, August 27th. The stock was sold at an average price of $74.10, for a total value of $24,638,250.00. Following the completion of the transaction, the chief executive officer directly owned 9,207,533 shares in the company, valued at approximately $682,278,195.30. This trade represents a 3.49% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO James William Rogers sold 7,528 shares of Tempus AI stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $74.65, for a total value of $561,965.20. Following the completion of the transaction, the chief financial officer owned 138,473 shares of the company's stock, valued at approximately $10,337,009.45. This trade represents a 5.16% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 601,787 shares of company stock valued at $42,492,268. Corporate insiders own 26.27% of the company's stock.

Tempus AI Trading Up 1.3%

Shares of TEM traded up $1.17 during midday trading on Friday, hitting $88.24. 17,651,091 shares of the stock were exchanged, compared to its average volume of 8,194,459. Tempus AI, Inc. has a 52-week low of $31.36 and a 52-week high of $91.45. The stock has a fifty day simple moving average of $70.46 and a 200 day simple moving average of $60.74. The firm has a market cap of $15.33 billion, a P/E ratio of -74.15 and a beta of 5.08. The company has a debt-to-equity ratio of 2.58, a quick ratio of 1.43 and a current ratio of 1.54.

Tempus AI (NASDAQ:TEM - Get Free Report) last released its quarterly earnings results on Friday, August 8th. The company reported ($0.22) EPS for the quarter, topping the consensus estimate of ($0.23) by $0.01. Tempus AI had a negative return on equity of 122.86% and a negative net margin of 20.98%.The business had revenue of $314.64 million during the quarter, compared to analyst estimates of $296.84 million. During the same period last year, the business posted ($6.86) earnings per share. The company's quarterly revenue was up 89.5% on a year-over-year basis. Tempus AI has set its FY 2025 guidance at EPS. On average, research analysts anticipate that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.

Tempus AI Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.